Skip to main content

The latest developments in oncology R&D

Oncology has long been pharma’s biggest bucket for R&D, with investment historically leading to some of pharma’s most impactful breakthroughs. In the coming years, innovations such as radiopharmaceuticals, new immunotherapies, and next-generation cell and gene therapies offer cutting-edge solutions in cancer care.

included in this trendline
  • Can China sustain a surge in oncology drug innovation?
  • With ADCs on the rise, drugmakers embrace a new oncology pillar
  • How leading oncology drugmakers set the stage for future advances
Our Trendlines go deep on the biggest trends. These special reports, produced by our team of award-winning journalists, help business leaders understand how their industries are changing.
Davide Savenije Editor-in-Chief at Industry Dive.